Colorado Therapeutics Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.57M
Colorado Therapeutics General Information
Description
Developer of tissue processing technology designed to produce strong, durable, and biocompatible tissue from xenogenic sources. The company's technology focuses on developing xenogenic biologic tissue matrix products and therapeutic devices for a broad range of soft tissue reinforcement, and regenerative and vascular applications, enabling medical professionals to effectively address unmet patient needs in soft tissue repair.
Contact Information
Website
www.co-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
- 486 South Pierce Avenue
- Suite A
- Louisville, CO 80027
- United States
+1 (303) 000-0000
Colorado Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 17-Apr-2017 | $2.57M | 00.000 | Completed | Generating Revenue | |
| 1. Seed Round | 18-Apr-2016 | 00.00 | 00.00 | Completed | Generating Revenue |
Colorado Therapeutics Executive Team (4)
Colorado Therapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Gleeson | Colorado Therapeutics | Board Member | 000 0000 |
| Thomas Reagan | Colorado Therapeutics | Corporate and Financial Advisor & Board Member | 000 0000 |
Colorado Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
